Home ›
Trademark Categories ›
Pharmaceuticals ›
2013 ›
RE ›
REESANZ
Trademark search for:
REESANZ
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-08-16 — Application filed
2016-08-19 — Application filed
2016-08-19 — Application filed
2016-09-27 — Assigned to examiner
2016-09-28 — Final disposition recorded
2016-09-28 — Final disposition recorded
2016-09-28 — Final disposition recorded
2017-03-23 — Office action issued
2017-04-06 — Assigned to lie
2017-04-12 — Correspondence received in law office
2017-04-12 — Teas/email correspondence entered
2017-04-24 — Approved for pub - principal register
2017-04-26 — Law office publication review completed
2017-05-10 — Notification of notice of publication e-mailed
2017-05-30 — Published for opposition
2017-05-30 — Official gazette publication confirmation e-mailed
2017-07-25 — Noa e-mailed - sou required from applicant
2018-01-24 — Sou teas extension received
2018-01-24 — Sou extension 1 filed
2018-01-24 — Sou extension 1 granted
2018-01-26 — Notice of approval of extension request e-mailed
2018-07-14 — Sou teas extension received
2018-07-14 — Sou extension 2 filed
2018-07-14 — Sou extension 2 granted
2018-07-17 — Notice of approval of extension request e-mailed
2019-01-21 — Sou teas extension received
2019-01-21 — Sou extension 3 filed
2019-01-21 — Sou extension 3 granted
2019-01-23 — Notice of approval of extension request e-mailed
2019-07-12 — Sou teas extension received
2019-07-12 — Sou extension 4 filed
2019-07-12 — Sou extension 4 granted
2019-07-16 — Notice of approval of extension request e-mailed
2020-01-20 — Sou teas extension received
2020-01-20 — Sou extension 5 filed
2020-01-23 — Case assigned to intent to use paralegal
2020-01-23 — Sou extension 5 granted
2020-01-24 — Notice of approval of extension request e-mailed
2020-08-31 — Application abandoned
2020-08-31 — Application abandoned
2020-08-31 — Final status recorded
Owner Information
Novartis AG
Novartis AG
Correspondent
MAURY M. TEPPER, III TEPPER & EYSTER, PLLC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
